These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33891324)

  • 1. Anaesthetic implications for a malignant hyperthermia-susceptible fetus.
    Nestor CC; Kearsley R; Irwin MG
    Anaesthesia; 2021 Sep; 76(9):1281-1282. PubMed ID: 33891324
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaesthetic management of a parturient patient with a malignant hyperthermia partner.
    Dolan R; Corcoran F
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35396237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.
    Pollock N; Langton EE; Stowell KM; Bulger TF
    Anaesth Intensive Care; 2011 Sep; 39(5):887-94. PubMed ID: 21970134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Emmanuel ER
    Anaesthesia; 1988 Aug; 43(8):666-70. PubMed ID: 3421459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
    Krivosic-Horber R; Theunynck D; Krivosic I; Adnet P; Guévart E
    Ann Fr Anesth Reanim; 1986; 5(3):326-9. PubMed ID: 3777561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatile anesthetics inhibit dihydropyridine binding to malignant hyperthermia-susceptible and normal pig skeletal muscle membranes.
    Louis CF; Roghair T; Mickelson JR
    Anesthesiology; 1994 Mar; 80(3):618-24. PubMed ID: 8141457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaesthetic considerations for a possible malignant hyperthermia susceptible fetus.
    Hersch PE; Matheson KH
    Anaesthesia; 1996 Jan; 51(1):99. PubMed ID: 8669595
    [No Abstract]   [Full Text] [Related]  

  • 8. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia.
    Glisson SN
    Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of propofol on the malignant hyperthermia susceptible pig model.
    Krivosic-Horber R; Reyfort H; Becq MC; Adnet P
    Br J Anaesth; 1989 Jun; 62(6):691-3. PubMed ID: 2787665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of amide local anesthetics in patients susceptible to malignant hyperthermia.
    Dershwitz M; Ryan JF; Guralnick W
    J Am Dent Assoc; 1989 Mar; 118(3):276, 278, 280. PubMed ID: 2646341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core myopathies and malignant hyperthermia susceptibility: a review.
    Brislin RP; Theroux MC
    Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
    Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
    Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual anesthetic course in a patient susceptible to malignant hyperthermia.
    Westlund UJ; Fridrich KL; Warner DS; Sokoll MD
    J Oral Maxillofac Surg; 1989 Aug; 47(8):860-4. PubMed ID: 2664105
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosed.
    Islander G; Henriksson KG; Ranklev-Twetman E
    Neuromuscul Disord; 1995 Mar; 5(2):125-7. PubMed ID: 7767091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of suspected malignant hyperthermia during desflurane administration.
    Celebioglu B
    Anesth Analg; 1998 Apr; 86(4):916. PubMed ID: 9539628
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized.
    Halsall PJ; Cain PA; Ellis FR
    Br J Anaesth; 1979 Oct; 51(10):949-54. PubMed ID: 518796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.